03.11.2014 Views

Enzygnost* Anti-HBs II - Medcorp

Enzygnost* Anti-HBs II - Medcorp

Enzygnost* Anti-HBs II - Medcorp

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Tab. 1 Storage and Stability<br />

Material/reagent State Storage Stability •<br />

Enzygnost * <strong>Anti</strong>-<strong>HBs</strong> <strong>II</strong> (Test plate) once opened +2 to +8 °C 4 weeks<br />

in the bag<br />

with the desiccant<br />

<strong>HBs</strong>Ag/POD Conjugate (anti-<strong>HBs</strong> <strong>II</strong>) once opened +2 to +8 °C 4 weeks<br />

<strong>Anti</strong>-<strong>HBs</strong> Serum 100 once opened +2 to +8 °C 4 weeks<br />

<strong>Anti</strong>-<strong>HBs</strong> Serum, negative < -20° C 3 months<br />

Chromogen TMB once opened +2 to +8 °C expiry date<br />

Buffer/Substrate TMB once opened +2 to +8 °C expiry date<br />

Working Chromogen Solution diluted +2 to +8 °C 5 days<br />

1 + 10 +15 to +25 °C 8 hours<br />

in closed container<br />

protected from light<br />

Washing Solution POD (concentrate) once opened +2 to +8 °C expiry date<br />

diluted 1:20 +2 to +8 °C 1 week<br />

diluted 1:20 +18 to +25 °C 1 day<br />

Stopping Solution POD once opened +2 to +8 °C expiry date<br />

• use each component by the expiry date at the latest<br />

Tab. 2 Sensitivity<br />

The sensitivity studies, run at different sample panels, yielded the following data:<br />

Sample population Number Enzygnost * <strong>Anti</strong>-<strong>HBs</strong> <strong>II</strong><br />

of samples<br />

reactive<br />

<strong>Anti</strong>-<strong>HBs</strong> positive (Germany) 106 106<br />

<strong>Anti</strong>-<strong>HBs</strong> positive (America) 52 52<br />

Follow-up samples 25 25<br />

<strong>Anti</strong>-<strong>HBs</strong> positive 100 100<br />

Different stages of HBV infection 41 41<br />

HBV vaccinees 111 111<br />

anti-<strong>HBs</strong> positive 80 80<br />

vaccination profiles 32 profiles Sensitivity equivalent<br />

seroconversion 9 profiles to that of<br />

comparable tests<br />

Tab. 3 Specificity<br />

The specificity studies, run with samples from different blood banks, yielded the following data:<br />

Sample population Number Enzygnost * <strong>Anti</strong>-<strong>HBs</strong> <strong>II</strong><br />

of samples<br />

reactive<br />

Normal negative sera 2296 11<br />

Normal negative plasmas 646 2<br />

Normal negative sera 1508 5<br />

Normal negative plasmas 286 1<br />

OQNE G11 C0541 (906) H/R 10

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!